InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Ronsheim Matthew, 管理人员. Director active across 2 companies, notably Entasis Therapeutics Holdings Inc.. Cumulatively, 8 disclosures have been logged. History available since 19 October 2021. The latest transaction was filed on 20 May 2024 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Ronsheim Matthew is an executive associated with Innoviva, Inc. and Entasis Therapeutics Holdings Inc. The declarant has 8 filings in total, and the 8 sampled filings cover the period from 2021-10-20 to 2024-05-21, with the dominant transaction nature listed as tax withholding.